XML 145 R19.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Schedule of Fair Value Measurements

 

(in thousands)  (Level 1)   (Level 2)   (Level 3)   Total 
   Fair Value Measurements at December 31, 2021 
   Quoted Prices in Active Markets for Identical Assets   Other Observable Inputs   Significant Unobservable Inputs     
(in thousands)  (Level 1)   (Level 2)   (Level 3)   Total 
Derivative liability  $-   $-   $7,697   $7,697 
Total  $-   $-   $7,697   $7,697 
Schedule of Roll Forward of Level 3 Financial Instruments

A roll forward of the level 3 valuation financial instruments is as follows:

 

                
  

Year Ended

December 31, 2021

 
(In thousands)  Warrants   Notes   Total 
Balance at December 31, 2020  $   $   $ 
Initial valuation of derivative liabilities included in debt discount       377    377 
Initial valuation of derivative liabilities included in derivative expense   246    1,348    1,594 
Reclassification of derivative liabilities gain to loss on debt extinguishment   (52)   (193)   (245)
Reclass from additional paid-in capital   3,107    355    3,462 
Change in fair value included in derivative expense   2,035    474    2,509 
Balance at December 31, 2021  $5,336   $2,361   $7,697 
Schedule of Earnings Per Share, Basic and Diluted

The following table presents the computation of net loss per share (in thousands, except share and per share data):

 

(in thousands except share and per share data)  2021   2020 
   December 31, 
(in thousands except share and per share data)  2021   2020 
Numerator        
Net loss  $(6,351)  $(3,766)
Preferred stock dividends   (2,054)   (1,540)
Net Loss allocable to common stockholders  $(8,405)  $(5,306)
Denominator          
Weighted average common shares outstanding used to compute net loss per share, basic and diluted   13,003,658    10,876,513 
Net loss per share of common stock, basic and diluted          
Net loss per share, basic and diluted  $(0.65)  $(0.49)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following number of shares have been excluded from diluted net (loss) since such inclusion would be anti-dilutive:

 

   2021   2020 
   Year Ended December 31, 
   2021   2020 
Stock options outstanding   384,050    391,350 
Convertible notes   48,696,732    33,658,590 
Warrants   74,625,139    78,181,855 
Series C Preferred Stock   66,667    66,667 
Series D Preferred Stock   50,000    50,000 
Series E Preferred Stock   43,240,749    42,055,232 
Series F Preferred Stock   4,555,010    4,303,767 
Total   171,618,347    158,707,461